The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

The California Public Employees’ Retirement System (CalPERS) has a new pharmacy benefits contract with CVS Caremark, the ...

Nuvem, a tech-enabled pharmacy service for community health providers, announced the addition of four seasoned executives to ...

GLP-1s drive a historic shift in traditional drug spending increases, outpacing specialty drug trends for the first time.

CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement ...

For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

Community members rally to save their CVS location on Pennsylvania Avenue SE, citing the importance of accessible health care ...

CVS Pharmacy Inc. and Vi-Jon LLC convinced a federal appeals court not to revive a proposed class action over their hand ...

Review CVS Health Corp (CVS:XNYS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

CVS Health’s CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supported ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.